Back to VVUS Stock Lookup

VVUS Related Analyst Ratings

May 14, 2013 07:35 AM UPDATE: Lazard Capital Downgrades Vivus (VVUS) to Neutral

May 8, 2013 03:06 PM Brean Capital Maintains Sell of Vivus (VVUS), Notes Slower April Growth

Apr 30, 2013 10:58 AM VIVUS (VVUS) Inks Qsymia Deal with MEDCO; 'Executing Well' Says Analyst

Apr 17, 2013 08:44 AM Jefferies Remains Cautious on Vivus (VVUS) Despite Qsymia REMS Expansion

Apr 9, 2013 03:33 PM VIVUS, Inc. (VVUS) Positive; Shorts Cover Into REMS Modification for Qsymia

Mar 27, 2013 08:21 AM Leerink Swann Reiterates Outperform on VIVUS (VVUS), Review in Health Economics A Positive

Mar 26, 2013 12:56 PM Vivus (VVUS) Financing Agreement Does Not Appear Cheap - Analyst

Mar 5, 2013 04:18 PM Piper Jaffray Starts Vivus (VVUS) at Overweight, PT of $17

Mar 4, 2013 02:18 PM Needham Sees Strong Start for Arena's (ARNA) Belviq in U.S.; European Approval Unlikely

Mar 4, 2013 10:08 AM VIVUS (VVUS) Cuts Qsymia Price by About 70%; Arena (ARNA) on Watch

Feb 26, 2013 09:23 AM VIVUS, Inc. (VVUS) Misses Q4 Views on Heftier Qsymia Costs; Analysts Comment

Feb 26, 2013 08:21 AM Needham & Company Sees 2nd-Half Qsymia Ramp for Vivus (VVUS)

Feb 25, 2013 01:15 PM Arena (ARNA) Will Need Lower Co-Payments, Broader Coverage for Belviq Success (VVUS)

Feb 6, 2013 07:17 AM Leerink Swann Resumes Vivus (VVUS) at Outperform, $19-$20 Valuation

Feb 4, 2013 10:45 AM VIVUS, Inc. (VVUS) Qsymia Prescriptions Show Gains During Slow Holiday Week (ARNA) (OREX)

Jan 17, 2013 07:41 AM Brean Capital Downgrades Vivus (VVUS) to Sell, Low Qsymia Coverage Means Low Sales

Jan 7, 2013 06:50 AM BofA/Merrill Lynch added Vivus (VVUS) to U.S. 1 List

Jan 4, 2013 03:25 PM Despite Slow Launch, Vivus's (VVUS) Qsymia Still Has Blockbuster Potential

Dec 31, 2012 12:13 PM VIVUS (VVUS) Qsymia Sales Lag Investor Sentiment in Nov.; Many Expect Better FY13

Dec 24, 2012 10:36 AM Express Scripts (ESRX) Deal is Huge Win for VIVUS (VVUS); Qsymia Reimbursement Will Improve

Dec 21, 2012 11:56 AM JPMorgan Confident Orexigen's (OREX) Will Receive FDA Approval; Comments on Meeting

Dec 18, 2012 03:23 PM Orexigen (OREX) Slumps as Many Expected 'Better News' for Contrave

Dec 17, 2012 09:46 AM Vivus (VVUS) Surges as Qsymia Prescriptions Rise 46%

Dec 10, 2012 09:10 AM VIVUS (VVUS) Qsymia Prescriptions Pop Following Thanksgiving Glut (ARNA) (OREX)

Nov 7, 2012 12:33 PM Jefferies Slashes Numbers on Vivus (VVUS) on Slow Qsymia Uptake; Sees Another 45% Downside

Nov 7, 2012 11:26 AM Jefferies Remains Bullish on Arena Pharma (ARNA) But Tempers Valuation Target on Data from Rival

Nov 6, 2012 03:02 PM Needham & Company Cuts Numbers on VIVUS Inc. (VVUS) on Slower Qsymia Launch, Keeps Buy on Blockbuster Potential

Nov 6, 2012 12:20 PM VIVUS (VVUS) Sell Off Overdone; Wells Says All Drugs Have Abandonment, Co-Pay Issues

Nov 5, 2012 12:31 PM VIVUS (VVUS) Qsymia Prescriptions Now Said to Be Up 25% in Week 6, In-Line with Views

Nov 5, 2012 10:16 AM VIVUS (VVUS) Lower; Data Shows Unexpected Drop in Qsymia Prescriptions for Week 6 - BI

Oct 31, 2012 02:18 PM Latest Qsymia Data Shapes Up Potential Bear Case for VIVUS (VVUS) and Peers (ARNA) (OREX)

Oct 26, 2012 11:58 AM VIVUS (VVUS) Qsymia Prescriptions Remain High Amid Birth Defect Warning; Positive for Arena (ARNA)

Oct 22, 2012 10:08 AM VIVUS (VVUS) Qsymia Prescriptions Keep Chugging, Gain 27%+ Last Week

Oct 19, 2012 10:05 AM Wells Outlines Paths for VIVUS (VVUS) Following CHMP Denial of Qsiva Marketing App

Oct 15, 2012 11:18 AM VIVUS (VVUS) Qsymia Continues to See Strong Early Demand

Oct 9, 2012 01:04 PM VIVUS (VVUS) Higher as Qsymia Prescriptions Show Confident Growth

Oct 8, 2012 12:48 PM VIVUS' (VVUS) Qsymia Prescription Insurer Pay Rate Rose 5% in Week Two

Sep 24, 2012 04:39 PM Vivus (VVUS) Slammed; Analyst Sees 38% Downside

Sep 24, 2012 07:31 AM Needham & Company Cuts Target on Vivus (VVUS), Adjusts Qsymia Estimates

Sep 21, 2012 12:19 PM Not Expecting E.U. Approval for Vivus' (VVUS) Qsiva, Could be a Plus for Orexigen (OREX) - Analyst

Sep 21, 2012 07:45 AM Roth Capital 'Materially' Raises VIVUS (VVUS) Qsymia Sales Expectations; Remains Near-Term Cautious

Sep 10, 2012 11:36 AM No Love for Vivus (VVUS) at Obesity Conference

Sep 6, 2012 03:42 PM Orexigen (OREX) Surges On 'Aggressive' Buy Calls Ahead of Catalysts

Aug 17, 2012 07:12 AM Jefferies Downgrades Vivus (VVUS) to Underperform On Generic Risk

Aug 7, 2012 06:41 AM Lazard Capital Upgrades Vivus (VVUS) to Buy

Aug 6, 2012 09:19 AM Sell-Off in VIVUS (VVUS) Over Qsymia Patent Concerns is Overdone - Analyst

Jul 20, 2012 08:40 AM Analyst Says Citron Note Creates Buying Opportunity in VIVUS (VVUS)

Jul 18, 2012 03:14 PM Wells Fargo Lifts Valuation Range on Vivus (VVUS), But Still Not Overly Bullish

Jul 18, 2012 01:32 PM Brean Murray Carret & Co. Downgrades Vivus (VVUS); Qsymia Approval Huge, But Struggling with Valuation Until Launch Proves Otherwise

Jul 18, 2012 09:08 AM VIVUS' (VVUS) Qsymia Approved and has Advantages Over Belviq

Back to VVUS Stock Lookup